top of page

Search

Solaris Admin
- Aug 29, 2020
- 1 min read

August 30, 2020

Updated: Mar 11, 2021

Solaris Pharma Corporation located in Bridgewater, New Jersey is pleased to announce the launch of Clindamycin Phosphate Gel USP, 1% supplied in 30 g and 60 g tubes. For additional information, please visit the products page or email us directly at info@solaris-pharma.com

Recent Posts

Solaris Pharma Corporation is pleased to announce the product approval of Tazarotene Gel, 0.05% and 0.1%.

Aug 23, 2021 - Press Release

Solaris Pharma Corporation located Bridgewater, New Jersey announces the final approval from U.S Food and Drug Administration for its...

Comments

bottom of page